meropenem and Cytokine-Release-Syndrome

meropenem has been researched along with Cytokine-Release-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for meropenem and Cytokine-Release-Syndrome

ArticleYear
One-year-old boy with refractory Listeria monocytogenes meningitis due to persistent hypercytokinemia.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:12

    We had a case of Listeria monocytogenes (LM) meningitis complicated with hypercytokinemia and hemophagocytic lymphohistiocytosis in a healthy 22-month-old boy. He was admitted to our hospital with a fever, vomiting, mild consciousness disturbances, and extraocular muscle paralysis. Magnetic resonance imaging (MRI) revealed bilateral deep white matter lesions. After receiving ampicillin, meropenem, and gentamicin, his cerebrospinal fluid (CSF) culture results turned negative on the third day of hospitalization. However, the fever intermittently persisted, and it took approximately 40 days to completely resolve. During this period, various inflammatory cytokine levels, particularly neopterin, in the blood and CSF remained elevated. Therefore, long-term administration of corticosteroids in addition to antibiotics was required. The use of dexamethasone appeared to be effective for neurological disorders such as consciousness disturbance and extraocular muscle paralysis associated with abnormal brain MRI findings. LM meningitis may present with encephalopathy and persistent fever due to hypercytokinemia. In such cases, corticosteroid therapy should be considered.

    Topics: Adrenal Cortex Hormones; Ampicillin; Anti-Bacterial Agents; Cytokine Release Syndrome; Cytokines; Dexamethasone; Gentamicins; Humans; Infant; Listeria monocytogenes; Male; Meningitis, Listeria; Meropenem; Neopterin; Paralysis

2022